Dameda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,771,617 | 1,818,910 | 1,847,804 | 1,555,473 | 2,001,047 | 1,464,263 | 1,612,437 | 1,076,896 |
| Profit before tax | 36,571 | 140,129 | 82,387 | 11,501 | 63,322 | -75,892 | 5,913 | -154,765 |
| Net profit | 30,127 | 118,766 | 69,769 | 9,505 | 53,413 | -75,892 | 3,960 | -154,765 |
| Equity | 1,910,121 | 1,973,887 | 1,988,656 | 1,948,161 | 1,951,574 | 1,701,069 | 1,700,029 | 1,547,255 |
| Liabilities | 91,952 | 2,176 | 2,176 | 2,176 | 2,176 | 0 | 0 | 0 |
| Non-current assets | 457,682 | 459,134 | 458,895 | 453,830 | 452,915 | 445,047 | 473,145 | 443,069 |
| Current assets | 1,544,391 | 1,516,929 | 1,531,937 | 1,496,507 | 1,500,835 | 1,256,022 | 1,226,884 | 1,104,186 |
| Total assets | 2,002,073 | 1,976,063 | 1,990,832 | 1,950,337 | 1,953,750 | 1,701,069 | 1,700,029 | 1,547,255 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 192,140 | 117,424 | 84,818 |
| Social insurance contributions | - | - | - | - | - | 84,789 | 82,088 | 62,117 |
|
Financial indicators
|
||||||||
| Revenue change y/y | 0.0% | +2.7% | +1.6% | -15.8% | +28.6% | -26.8% | +10.1% | -33.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.5% | 6.0% | 3.5% | 0.5% | 2.7% | -4.5% | 0.2% | -10.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.6% | 6.0% | 3.5% | 0.5% | 2.7% | -4.5% | 0.2% | -10.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.7% | 6.5% | 3.8% | 0.6% | 2.7% | -5.2% | 0.2% | -14.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.1% | 7.7% | 4.5% | 0.7% | 3.2% | -5.2% | 0.4% | -14.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 118,108 | 121,261 | 116,092 | 91,052 | 117,709 | 86,133 | 110,567 | 97,900 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dameda - Social security debts
The company had no debts to Sodra
Dameda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dameda, UAB (code 123322285) is a private limited liability company operating in the wholesale of pharmaceutical and medical goods. In 2025, revenue declined to €1.08M from €1.61M in 2024, a year-on-year decrease of 33.2%. Net profit returned to a loss of €154.8K in 2025 after a small profit of €4.0K in 2024, and the profit margin fell to -14.4%. The 2023–2025 pattern shows a temporary improvement in 2024 followed by a weaker 2025 result, after a loss of €75.9K in 2023. Balance-sheet size also contracted: total assets and equity were both €1.55M in 2025, compared with €1.70M in both 2023 and 2024. Long-term assets stood at €443.1K and short-term assets at €1.10M. Key efficiency indicators for 2025 were a return on equity of -10.0%, return on assets of -10.0%, asset turnover of 0.70x, and revenue per employee of €97.9K. Profit per employee was -€14.1K.